The DOI matches its Crossref record; 85 of the 87 references it cites were found in a registry or an index.
Friedreich's ataxia: Pathology, pathogenesis, and molecular genetics
Open accessAbstract
The pathogenic mutation in Friedreich's ataxia (FRDA) is a homozygous guanine-adenine-adenine (GAA) trinucleotide repeat expansion on chromosome 9q13 that causes a transcriptional defect of the frataxin gene. Deficiency of frataxin, a small mitochondrial protein, is responsible for all clinical and morphological manifestations of FRDA. This autosomal recessive disease affects central and peripheral nervous systems, heart, skeleton, and endocrine pancreas. Long expansions lead to early onset, severe clinical illness, and death in young adult life. Patients with short expansions have a later onset and a more benign course. Some are not diagnosed during life. The neurological phenotype reflects lesions in dorsal root ganglia (DRG), sensory peripheral nerves, corticospinal tracts, and dentate nuclei (DN). Most patients succumb to cardiomyopathy, and many become diabetic during the course of their disease. This review seeks to reconcile the diverse clinical features with pathological and molecular data. In the pathogenesis of the lesion in DRG, dorsal spinal roots, and sensory peripheral nerves, developmental defects and atrophy occur in combination. The progressive lesion of the DN lacks a known developmental component. Destruction of the DN, optic atrophy, and degeneration of the corticospinal tracts are intrinsic central nervous system lesions. Fiber loss in dorsal columns and spinocerebellar tracts, and atrophy of the neurons in the dorsal nuclei of Clarke are secondary to the lesion in DRG. The role of frataxin deficiency in the pathogenesis of FRDA is still unclear because the protein has multiple functions in the normal state, including biogenesis of iron-sulfur clusters; iron chaperoning; iron storage; and control of iron-mediated oxidative tissue damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Decreased expression of frataxin also increases the Fenton reaction due to excess free iron (17, 220).”
From Redox regulation of mitochondrial function (2012) · cites this paper as [220]
In the citing paper
“In addition, the hypoxia-induced suppression of Fe-S protein activity can be contrasted with the suppression of Fe-S protein activity found in Friedreich's ataxia, a hereditary neurogenerative disease that results from decreased production/function of the frataxin protein (17, 220).”
From Redox regulation of mitochondrial function (2012) · cites this paper as [220]
In the citing paper
“Histological studies and MRI suggest that in human brains the highest iron accumulation occurs in the dentate nuclei of the cerebellum.166,167”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [167]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging
Mori, S., Crain, B. J., Chacko, V. P., & van Zijl, P. C. M. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199902)45:2 · Cited by 3,513
Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion
Campuzano, V., Montermini, L., Moltò, M. D., Pianese, L., Cossée, M., Cavalcanti, F., Monros, E., Rodius, F., Duclos, F., Monticelli, A., et al. (1996) · Science · doi:10.1126/science.271.5254.1423 · Cited by 2,786
Clinical and Genetic Abnormalities in Patients with Friedreich's Ataxia
Dürr, A., Cossee, M., Agid, Y., Campuzano, V., Mignard, C., Penet, C., Mandel, J.-L., Brice, A., & Koenig, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351601 · Cited by 1,071
Aconitase and mitochondrial iron–sulphur protein deficiency in Friedreich ataxia
Rötig, A., de Lonlay, P., Chretien, D., Foury, F., Koenig, M., Sidi, D., Munnich, A., & Rustin, P. (1997) · Nature Genetics · doi:10.1038/ng1097-215 · Cited by 991
Harding, A. E. (1981) · Brain · doi:10.1093/brain/104.3.589 · Cited by 929
Regulation of Mitochondrial Iron Accumulation by Yfh1p, a Putative Homolog of Frataxin
Babcock, M., de Silva, D., Oaks, R., Davis-Kaplan, S., Jiralerspong, S., Montermini, L., Pandolfo, M., & Kaplan, J. (1997) · Science · doi:10.1126/science.276.5319.1709 · Cited by 921
Puccio, H., Simon, D., Cossée, M., Criqui-Filipe, P., Tiziano, F., Melki, J., Hindelang, C., Matyas, R., Rustin, P., & Koenig, M. (2001) · Nature Genetics · doi:10.1038/84818 · Cited by 738
Richardson, D. R., Lane, D. J. R., Becker, E. M., Huang, M. L.-H., Whitnall, M., Rahmanto, Y. S., Sheftel, A. D., & Ponka, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912925107 · Cited by 536
Filla, A., Michele, G. D., Cavalcanti, F., Pianese, L., Monticelli, A., Campanella, G., & Cocozza, S. (1996) · PubMed Central · Cited by 487
Selective iron chelation in Friedreich ataxia: biologic and clinical implications
Boddaert, N., Le Quan Sang, K. H., Rötig, A., Leroy-Willig, A., Gallet, S., Brunelle, F., Sidi, D., Thalabard, J.-C., Munnich, A., & Cabantchik, Z. I. (2007) · Blood · doi:10.1182/blood-2006-12-065433 · Cited by 409
Research works printed but not linked: 2
- Mott, 1907, Case of Friedreich's disease, with autopsy and systematic microscopical examination of the nervous system, Arch Neurol Psychiat Lond, 3, 180
- Vassilopoulos, 1977, Étude radiologique de la colonne vertébrale cervicale dans certaines maladies dégéneratives neurologiques, J Radiol Électrol Méd Nucl, 58, 183
Cited by
Sorted by citations
Items 201–300 of 452
Rastokina, A., Cebrián, J., Mozafari, N., Mandel, N. H., Smith, C. I. E., Lopes, M., Zain, R., & Mirkin, S. M. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad441 · Cited by 17
Nitric oxide prevents Aft1 activation and metabolic remodeling in frataxin-deficient yeast
Alsina, D., Ros, J., & Tamarit, J. (2017) · Redox Biology · doi:10.1016/j.redox.2017.09.001 · Cited by 14
Yu, Z., Lin, K., Chen, J., Chen, K., Guo, W., Dai, Y., Chen, Y., Zou, X., & Peng, X. (2020) · BMC Neurology · doi:10.1186/s12883-020-01945-4 · Cited by 17
Sliwa, D., Dairou, J., Camadro, J., & Santos, R. (2011) · Biochemical Journal · doi:10.1042/bj20111574 · Cited by 17
Patient-Reported Impact of Symptoms in Friedreich Ataxia
Seabury, J., Alexandrou, D., Dilek, N., Cohen, B., Heatwole, J. M., Larkindale, J., Lynch, D. R., Park, C. C., Rosero, S. J., Subramony, S. H., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000201598 · Cited by 16
Dionisi, C., Chazalon, M., Rai, M., Keime, C., Imbault, V., Communi, D., Puccio, H. M., Schiffmann, S. N., & Pandolfo, M. (2022) · Brain Communications · doi:10.1093/braincomms/fcad007 · Cited by 18
The cerebellar phenotype of Charcot-Marie-Tooth neuropathy type 4C
Skott, H., Muntean-Firanescu, C., Samuelsson, K., Verrecchia, L., Svenningsson, P., Malmgren, H., Cananau, C., Espay, A. J., Press, R., Solders, G., et al. (2019) · Cerebellum & Ataxias · doi:10.1186/s40673-019-0103-8 · Cited by 16
SS-31 efficacy in a mouse model of Friedreich ataxia by upregulation of frataxin expression
Liu, Y., Cai, J., Shen, J., Dong, W., Li, X., Fang, M., Lin, Y., Liu, J., Ding, Y., Qiao, T., et al. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab232 · Cited by 16
Bettencourt, C., Quintáns, B., Ros, R., Ampuero, I., Yáñez, Z., Pascual, S. I. P., de Yébenes, J. G., & Sobrido, M. (2012) · Human Mutation · doi:10.1002/humu.22148 · Cited by 16
Claves para afrontar el reto diagnóstico de las heredoataxias recesivas
Arias, M. (2016) · Neurología · doi:10.1016/j.nrl.2016.06.006 · Cited by 16
Mishra, R. K., Nunes, A. S., Enriquez, A., Profeta, V., Wells, M., Lynch, D. R., & Vaziri, A. (2024) · Communications Medicine · doi:10.1038/s43856-024-00653-1 · Cited by 15
Palandri, A., Martin, E., Russi, M., Rera, M., Tricoire, H., & Monnier, V. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.033811 · Cited by 15
Vestibular impact of Friedreich ataxia in early onset patients
Maudoux, A., Teissier, N., Francois, M., Abbeele, T. V. D., Alberti, C., Husson, I., & Vacher, S. R. W. (2020) · Cerebellum & Ataxias · doi:10.1186/s40673-020-00115-z · Cited by 16
The Cerebellar Cognitive Affective Syndrome and the Neuropsychiatry of the Cerebellum
Schmahmann, J. D. (2016) · Springer eBooks · doi:10.1007/978-3-319-24551-5_68 · Cited by 14
Corben, L. A., Kashuk, S., Akhlaghi, H., Jamadar, S. D., Delatycki, M. B., Fielding, J., Johnson, B. P., Georgiou‐Karistianis, N., & Egan, G. F. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.05.057 · Cited by 16
Cardiomyopathy in Friedreich Ataxia
Jensen, M. K., & Bundgaard, H. (2012) · Circulation · doi:10.1161/circulationaha.112.095364 · Cited by 15
Straub, S., Mangesius, S., Emmerich, J., Indelicato, E., Nachbauer, W., Degenhardt, K. S., Ladd, M. E., Boesch, S., & Gizewski, E. R. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24701 · Cited by 14
Takazaki, K. A. G., Quinaglia, T., Venâncio, T., Martínez, A., Shah, R. V., Neilan, T. G., Jerosch‐Herold, M., Coelho‐Filho, O. R., & França, M. C. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246633 · Cited by 14
Du fer et du soufre dans les protéines
Py, B., & Barras, F. (2014) · médecine/sciences · doi:10.1051/medsci/20143012014 · Cited by 20
Vicente-Acosta, A., Herranz-Martín, S., Pazos, M. R., Galán-Cruz, J., Amores, M., Loría, F., & Díaz‐Nido, J. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106631 · Cited by 13
DNA repair abnormalities leading to ataxia: shared neurological phenotypes and risk factors
Gilmore, E. C. (2014) · Neurogenetics · doi:10.1007/s10048-014-0415-z · Cited by 14
Targeting Mitochondrial Metal Dyshomeostasis for the Treatment of Neurodegeneration
Liddell, J. R. (2015) · Neurodegenerative Disease Management · doi:10.2217/nmt.15.19 · Cited by 13
Phosphodiesterase Inhibitors Revert Axonal Dystrophy in Friedreich's Ataxia Mouse Model
Mollá, B., Muñoz-Lasso, D. C., Calap-Quintana, P., Fernandez-Vilata, A., de la Iglesia-Vayá, M., Pallardó, F. V., Moltó, M. D., Palau, F., & González‐Cabo, P. (2019) · Neurotherapeutics · doi:10.1007/s13311-018-00706-z · Cited by 13
Therapeutic Biomarkers in Friedreich’s Ataxia: a Systematic Review and Meta-analysis
Gavriilaki, M., Chatzikyriakou, E., Moschou, M., Arnaoutoglou, M., Sakellari, I., & Kimiskidis, V. Κ. (2023) · The Cerebellum · doi:10.1007/s12311-023-01621-6 · Cited by 13
Heart and Nervous System Pathology in Compound Heterozygous Friedreich Ataxia
Becker, A. B., Qian, J., Gelman, B. B., Yang, M. L., Bauer, P. O., & Koeppen, A. H. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlx047 · Cited by 13
Self-citationNanopore Fabrication and Application as Biosensors in Neurodegenerative Diseases
Lenhart, B. J., Wei, X., Zhang, Z., Wang, X., Wang, Q., & Liu, C. (2020) · Critical Reviews in Biomedical Engineering · doi:10.1615/critrevbiomedeng.2020033151 · Cited by 14
Mammalian mitochondrial iron–sulfur cluster biogenesis and transfer and related human diseases
Wenxin, Z., Xu, L., Hongting, Z., & Li, K. (2021) · Biophysics Reports · doi:10.52601/bpr.2021.200038 · Cited by 12
Kerestes, R., Cummins, H., Georgiou‐Karistianis, N., Selvadurai, L. P., Corben, L. A., Delatycki, M. B., Egan, G. F., & Harding, I. H. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11637-x · Cited by 14
Ast, T., Wang, H., Marutani, E., Nagashima, F., Malhotra, R. K., Ichinose, F., & Mootha, V. K. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad091 · Cited by 12
The Role of NRF2 in Trinucleotide Repeat Expansion Disorders
Chang, K., & Chen, C. (2024) · Antioxidants · doi:10.3390/antiox13060649 · Cited by 12
Mitochondrial cardiomyopathies: pathogenesis, diagnosis, and treatment
Maack, C., Dudek, J., Bertero, E., Tampakakis, E., & Vernon, H. J. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf491 · Cited by 12
Friedreich's Ataxia, Frataxin, PIP5K1B: Echo of a Distant Fracas
Bayot, A., & Rustin, P. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/725635 · Cited by 15
Atypical Friedreich ataxia in patients with FXN p.R165P point mutation or comorbid hemochromatosis
Ygland, E., Taroni, F., Gellera, C., Caldarazzo, S., Dunø, M., Soller, M., & Puschmann, A. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.04.018 · Cited by 12
Sayles, N. M., Napierala, J. S., Anrather, J., Diedhiou, N., Li, J., Напиерала, М., Puccio, H. M., & Manfredi, G. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.050114 · Cited by 11
Perlman, S., Anheim, M., Boesch, S., Lewis, J. H., & Lynch, D. R. (2025) · Neurology and Therapy · doi:10.1007/s40120-025-00752-8 · Cited by 11
Quesada, M. P., García‐Bernal, D., Pastor, D., Estirado, A., Blanquer, M., García-Hernández, A. M., Moraleda, J. M., & Martı́nez, S. (2019) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-019-00202-1 · Cited by 11
Friedreich's ataxia: new insights
Krasilnikova, M. M., Humphries, C. L., & Shinsky, E. M. (2023) · Emerging Topics in Life Sciences · doi:10.1042/etls20230017 · Cited by 12
Nerve ultrasound in Friedreich’s Ataxia: enlarged nerves as a biomarker of disease severity
Pietro, G. D., Cioffi, E., Falco, P., Galosi, E., Stefano, G. D., Stefano, G. D., Leone, C. M., Martines, V., Perotti, S., Casali, C., et al. (2024) · Clinical Neurophysiology · doi:10.1016/j.clinph.2024.01.004 · Cited by 11
Mehta, N. M., Chacko, P., Jin, J., Tran, T., Prior, T. W., He, X., Agarwal, G., & Raman, S. V. (2016) · Texas Heart Institute Journal · doi:10.14503/thij-14-4198 · Cited by 11
Progress in understanding Friedreich’s ataxia using human induced pluripotent stem cells
Schreiber, A. M., Misiorek, J. O., Napierala, J. S., & Напиерала, М. (2018) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2019.1562334 · Cited by 13
Kalvala, A. K., Khan, I., Gundu, C., & Kumar, A. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190718153901 · Cited by 11
Recent Advances in Modeling Mitochondrial Cardiomyopathy Using Human Induced Pluripotent Stem Cells
Pávez, M., & Cyganek, L. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.800529 · Cited by 12
Naquin, E. R., Garg, R., Chen, W. J., Karmakar, E., Prasad, A., Mandadi, S., Depala, K. S., Gopianand, J. S., & Gnana‐Prakasam, J. P. (2025) · Nutrients · doi:10.3390/nu17182964 · Cited by 10
HMTase Inhibitors as a Potential Epigenetic-Based Therapeutic Approach for Friedreich’s Ataxia
Sherzai, M., Valle, A., Perry, N. T., Kalef-Ezra, E., Al‐Mahdawi, S., Pook, M. A., & Virmouni, S. A. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00584 · Cited by 11
Agrò, M., & Díaz‐Nido, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218251 · Cited by 10
Szmulewicz, D. J. (2017) · Current Otorhinolaryngology Reports · doi:10.1007/s40136-017-0161-5 · Cited by 10
Significance of NT-proBNP and High-Sensitivity Troponin in Friedreich Ataxia
Legrand, L., Maupain, C., Monin, M., Ewenczyk, C., Isnard, R., Alkouri, R., Dürr, A., & Pousset, F. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061630 · Cited by 10
Characterising the Neuropathology and Neurobehavioural Phenotype in Friedreich Ataxia
Corben, L. A., Georgiou‐Karistianis, N., Bradshaw, J. L., Evans‐Galea, M. V., Churchyard, A., & Delatycki, M. B. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5434-2_11 · Cited by 10
IFN-γ for Friedreich Ataxia: Present Evidence
Wells, M., Seyer, L. A., Schadt, K. A., & Lynch, D. R. (2015) · Neurodegenerative Disease Management · doi:10.2217/nmt.15.52 · Cited by 10
Neurologic orphan diseases: Emerging innovations and role for genetic treatments
Kioutchoukova, I. P., Foster, D. T., Thakkar, R. N., Foreman, M. A., Burgess, B. J., Toms, R., Valero, E., & Lucke-Wold, B. P. (2023) · World Journal of Experimental Medicine · doi:10.5493/wjem.v13.i4.59 · Cited by 11
Hynes, S. M., Goldsberry, A., Henneghan, P. D., Murai, M., Shinde, A., Wells, J. A., Wu, L., Wu, T., Zahir, H., & Khan, S. (2024) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.2482 · Cited by 9
Šuťák, R., Seguin, A., García‐Serres, R., Oddou, J., Dancis, A., Tachezy, J., Latour, J., Camadro, J., & Lesuisse, E. (2012) · MicrobiologyOpen · doi:10.1002/mbo3.18 · Cited by 9
Acoustic Analyses of Prolonged Vowels in Young Adults With Friedreich Ataxia
Carson, C. P., Ryalls, J., Hardin-Hollingsworth, K., Normand, M. L., & Ruddy, B. H. (2015) · Journal of Voice · doi:10.1016/j.jvoice.2015.05.008 · Cited by 9
The significance of intercalated discs in the pathogenesis of Friedreich cardiomyopathy
Koeppen, A. H., Becker, A. B., Feustel, P. J., Gelman, B. B., & Mazurkiewicz, J. E. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.06.006 · Cited by 9
Self-citationSchreiber, A. M., Li, Y., Chen, Y., Napierala, J. S., & Напиерала, М. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.836476 · Cited by 9
Zhang, Y.-C., Wan, G., Wang, W., Li, Y., Yu, Y. Y., Zhang, Y., Chen, F., & Pan, W. (2019) · Insect Science · doi:10.1111/1744-7917.12714 · Cited by 8
Comprehensive Account of Sodium Imaging and Spectroscopy for Brain Research
Handa, P., Samkaria, A., Sharma, S., Arora, Y., & Mandal, P. K. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00027 · Cited by 8
Determining the Validity of Conducting Rating Scales in Friedreich Ataxia through Video
Tai, G., Corben, L. A., Woodcock, I. R., Yiu, E. M., & Delatycki, M. B. (2021) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13204 · Cited by 8
Brodsky, M. C. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3384-6_4 · Cited by 8
Maheshwari, S., Vilema-Enríquez, G., & Wade‐Martins, R. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00376-8 · Cited by 10
Changes detected in swallowing function in Friedreich ataxia over 12 months
Keage, M., Delatycki, M. B., Dyer, J., Corben, L. A., & Vogel, A. P. (2019) · Neuromuscular Disorders · doi:10.1016/j.nmd.2019.08.013 · Cited by 8
Autosomal recessive adult onset ataxia
Mišković, N., Stanković, I., Milovanović, A., & Kostić, V. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10763-8 · Cited by 9
Calatrava-Ferreras, L., Gonzalo‐Gobernado, R., Reimers, D., Herranz, A. S., Casarejos, M. J., Jiménez‐Escrig, A., Regadera, J., Velasco-Martin, J. P., Vallejo-Muñoz, M., Díaz-Gil, J. J., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122066 · Cited by 8
Long non-coding RNA TUG1 is downregulated in Friedreich’s ataxia
Koka, M., Li, H., Akther, R., Perlman, S., Wong, D. Y., Fogel, B. L., Lynch, D. R., & Chandran, V. (2024) · Brain Communications · doi:10.1093/braincomms/fcae170 · Cited by 7
Neurobehavioral toxicity of Cold plasma activated water following oral gavage in mice
El-Reda, G. A., Mahmoud, U. T., Ali, F. A. Z., Abdel‐Maksoud, F. M., Mahmoud, M. A. M., & El-Hossary, F. M. (2024) · NeuroToxicology · doi:10.1016/j.neuro.2024.08.007 · Cited by 7
Mitochondrial Transplantation as a Therapeutic Strategy for Inherited Mitochondrial Diseases
Singh, P. S., tahavvori, A., Kuschner, C. E., Espin, B. B., Kazmi, J. S., Ramos, S. V., Yin, T., Hayashida, K., Ito‐Hagiwara, K., Endo, Y., et al. (2026) · Advanced Science · doi:10.1002/advs.202523368 · Cited by 7
Synthetic Nucleic Acids and Treatment of Neurological Diseases
Corey, D. R. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.2089 · Cited by 7
Zahir, H., Murai, M., Wu, L., Valentine, M., & Hynes, S. M. (2025) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.6189 · Cited by 7
Cantrell, A. C., Zeng, H., & Chen, J. (2023) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001496 · Cited by 8
Gavriel, C., Thomik, A. A. C., Lourenço, P. R., Nageshwaran, S., Athanasopoulos, S., Sylaidi, A., Festenstein, R., & Faisal, A. A. (2015) · International IEEE/EMBS Conference on Neural Engineering · doi:10.1109/ner.2015.7146631 · Cited by 7
First Presentation of Diabetes as Diabetic Ketoacidosis in a Case of Friedreich’s Ataxia
Chakraborty, P. P., Ray, S., Bhattacharjee, R., Ghosh, S. K., Mukhopadhyay, P., Mukhopadhyay, S., & Chowdhury, S. (2015) · Clinical Diabetes · doi:10.2337/diaclin.33.2.84 · Cited by 7
Treatment of Friedreich's ataxia
Pandolfo, M. (2013) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2013.771578 · Cited by 7
Sensory Ganglionopathy and the Blink Reflex: Electrophysiological Features
Alam, T., Barker, A., Alix, J. J. P., Hadjivassiliou, M., & Rao, D. G. (2016) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2015.361 · Cited by 7
Microvascular pathology in Friedreich cardiomyopathy.
Koeppen, A. H., Qian, J., Travis, A., Sossei, A. B., Feustel, P. J., & Mazurkiewicz, J. E. (2020) · PubMed · doi:10.14670/hh-18-132 · Cited by 7
Self-citationSamber, B. D., Berghe, T. V., Meul, E., Bauters, S., Seyrich, M., Smet, J., Paepe, B. D., da Silva, J. C., Bohic, S., Cloetens, P., et al. (2019) · Journal of Synchrotron Radiation · doi:10.1107/s1600577519015510 · Cited by 7
Sudomotor dysfunction is frequent and correlates with disability in Friedreich ataxia
Takazaki, K. A. G., de Rezende, T. J. R., Martínez, A., González‐Salazar, C., Nucci, A., Lopes‐Cendes, Í., & França, M. C. (2018) · Clinical Neurophysiology · doi:10.1016/j.clinph.2018.08.017 · Cited by 7
Mozafari, N., Milagres, S., Umek, T., Rocha, C. S. J., Vargiu, C. M., Freyberger, F., Saher, O., Напиерала, М., Napierala, J. S., Blomberg, P., et al. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102541 · Cited by 8
Impact of Mobility Device Use on Quality of Life in Children With Friedreich Ataxia
Ejaz, R., Chen, S., Isaacs, C. J., Carnevale, A., Wilson, J., George, K., Delatycki, M. B., Perlman, S., Mathews, K. D., Wilmot, G. R., et al. (2018) · Journal of Child Neurology · doi:10.1177/0883073818764941 · Cited by 6
Altered Ca2+ responses and antioxidant properties in Friedreich's ataxia-like cerebellar astrocytes
Marullo, C., Croci, L., Giupponi, I., Rivoletti, C., Zuffetti, S., Bettegazzi, B., Cremona, O., Giunti, P., Ambrosi, A., Casoni, F., et al. (2024) · Journal of Cell Science · doi:10.1242/jcs.263446 · Cited by 6
Edzeamey, F. J., Ramchunder, Z., Gómez, A. V., Ge, H., Marobbio, C. M. T., Pourzand, C., & Virmouni, S. A. (2025) · Redox Report · doi:10.1080/13510002.2025.2505303 · Cited by 6
Characterization of Cardiac-Onset Initial Presentation in Friedreich Ataxia
Lynch, D. R., Subramony, S. H., Lin, K. Y., Mathews, K. D., Perlman, S., Yoon, G., & Rummey, C. (2024) · Pediatric Cardiology · doi:10.1007/s00246-024-03429-5 · Cited by 6
Genetics in cardiovascular diseases
Celeghin, R., Thiene, G., Bauce, B., Basso, C., & Pilichou, K. (2019) · Italian Journal of Medicine · doi:10.4081/itjm.2019.1186 · Cited by 6
Griso, O., & Puccio, H. M. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9784-8_15 · Cited by 6
The Cerebellar Cognitive Affective Syndrome and the Neuropsychiatry of the Cerebellum
Schmahmann, J. D. (2021) · Springer eBooks · doi:10.1007/978-3-030-23810-0_77 · Cited by 7
Microgliopathy as a primary mediator of neuronal death in models of Friedreich’s Ataxia
Pernaci, C., Johnson, A., Gillette, S., Warden, A. S., McCormick, C., Novak, S. W., Ramírez, G., Broersma, E. H., Mishra, P., Sivakumar, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66710-y · Cited by 9
Metabolic Determinants of Cerebellar Circuit Formation and Maintenance
González-Rodríguez, M., & Marin‐Valencia, I. (2023) · The Cerebellum · doi:10.1007/s12311-023-01641-2 · Cited by 5
Saini, A. K., Anil, N., Vijay, A. N., Mangla, B., Javed, S., Kumar, P., & Ahsan, W. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128288707240404051856 · Cited by 5
Characteristics of Adverse Events and Clinical Risks of Omaveloxolone Based on FAERS Data
Liu, H., Fan, D., Hong, T., Shen, Z., & Yao, K. (2025) · The Cerebellum · doi:10.1007/s12311-025-01873-4 · Cited by 5
Yaméogo, P., Aguilar, S., Prakash, T. P., Rigo, F., Lynch, D. R., Napierala, J. S., & Напиерала, М. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102617 · Cited by 5
Gradient of microstructural damage along the dentato‐thalamo‐cortical tract in Friedreich ataxia
Cocozza, S., Bosticardo, S., Battocchio, M., Corben, L. A., Delatycki, M. B., Egan, G. F., Georgiou‐Karistianis, N., Monti, S., Palma, G., Pane, C., et al. (2024) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.52048 · Cited by 5
Drosophila models for studying iron-related neurodegenerative diseases.
Zhu, Z.-J., Wu, K.-C., Qian, Z., Yung, W., & Ke, Y. (2014) · PubMed · Cited by 5
Routine Clinical Testing Underestimates Proprioceptive Deficits in Friedreich’s Ataxia
Borchers, S., Synofzik, M., Kiely, E., & Himmelbach, M. (2013) · The Cerebellum · doi:10.1007/s12311-013-0508-5 · Cited by 5
Rao, V. K., DiDonato, C. J., & Larsen, P. D. (2018) · Case Reports in Neurological Medicine · doi:10.1155/2018/8587203 · Cited by 5
Neurologic Conditions Associated with Cavus Foot Deformity
Visser, H. J., Wolfe, J., Kouri, R., & Aviles, R. (2021) · Clinics in Podiatric Medicine and Surgery · doi:10.1016/j.cpm.2021.03.001 · Cited by 5
Spinal cord‐predominant neuropathology in an adult‐onset case of POLR3A ‐related spastic ataxia
Sytsma, T. M., Chen, D., Rolf, B. A., Dorschner, M. O., Jayadev, S., Keene, C. D., Zhang, J., Bird, T. D., & Latimer, C. S. (2021) · Neuropathology · doi:10.1111/neup.12775 · Cited by 5
Keys to overcoming the challenge of diagnosing autosomal recessive spinocerebellar ataxia
Arias, M. (2018) · Neurología (English Edition) · doi:10.1016/j.nrleng.2018.07.001 · Cited by 6
Srinivasan, S. R., de Gusmão, C. M., Korecka, J. A., & Khurana, V. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00048-4 · Cited by 6
Branco, L. M. T., de Rezende, T. J. R., Reis, F., & França, M. C. (2023) · Seminars in Ultrasound CT and MRI · doi:10.1053/j.sult.2023.03.016 · Cited by 5
Gavriel, C., Thomik, A. A. C., Lourencco, P. R., Nageshwaran, S., Athanasopoulos, S., Sylaidi, A., Festenstein, R., & Faisal, A. A. (2015) · Wearable and Implantable Body Sensor Networks · doi:10.1109/bsn.2015.7299426 · Cited by 5
Martineau, L., Noreau, A., & Dupré, N. (2014) · Current Treatment Options in Neurology · doi:10.1007/s11940-014-0300-y · Cited by 5
Metadata
- Authors
- Koeppen, A. H.
- Affiliations
- Albany Stratton VA Medical Center Albany (US)
- Corresponding author
- Koeppen, Arnulf H.
- Venue
- Journal of the Neurological Sciences
- Publisher
- Elsevier BV
- Published
- 2011-04
- Volume
- 303
- Issue
- 1-2
- Pages
- 1-12
- ISSN
- 0022-510X (ISSN-L)
- PMC
- PMC3062632
- OpenAlex
- W1985093325
- Cited by
- 447
- References
- 87
- Citations by year
- 2026: 21 · 2025: 31 · 2024: 36 · 2023: 34 · 2022: 18 · 2021: 22 · 2020: 25 · 2019: 27 · 2018: 21 · 2017: 27 · 2016: 30 · 2015: 30 · 2014: 38 · 2013: 52 · 2012: 28
- FWCI
- 3.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the Neurological Sciences (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Friedreich's Ataxia Research Alliance
- National Ataxia Foundation
- National Institutes of Health
- Neurochemical Research, Inc.
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- Friedreich's ataxia, GAA trinucleotide repeat expansion, frataxin deficiency, frataxin gene, iron chaperone, dorsal root ganglia, sensory neuropathy, dentate nucleus, corticospinal tract degeneration, cardiomyopathy, diabetes mellitus, autosomal recessive disorder, pathogenesis, clinical phenotype
- MeSH terms
- Frataxin, Adolescent, Adult, Aged, Animals, Child, Child, Preschool, Disease Models, Animal, Female, Friedreich Ataxia, Humans, Infant, Male, Middle Aged, Spinal Cord, Age of Onset, Iron-Binding Proteins, History, 19th Century, History, 20th Century, History, 21st Century, Mice, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review